サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631467

ヘルスケア分析検査サービス市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年

Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Type, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 130 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケア分析検査サービス市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月18日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケア分析検査サービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、ヘルスケア分析検査サービスの世界市場規模は2030年までに254億7,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 8.41％で成長すると予測されています。ヘルスケア分析検査サービスのアウトソーシングの増加、バイオシミラーの需要拡大、臨床検査件数の増加などが産業の成長を促進する主要要因となっています。また、COVID-19のパンデミックも産業の成長に寄与しています。バイオシミラーはFDAの承認を受けた医薬品であり、生物製剤の承認された多くの特徴を共有しています。生物製剤と比較すると、バイオシミラー医薬品はより手頃な価格で効果的な治療が可能であり、今後数年間で需要が大幅に増加すると予測されています。

Sandoz International GmbHの記事では、バイオシミラーの開発において分析検査が重要なステップであることが強調されており、このようなサービスへの需要が高まっています。COVID-19の世界的大流行は、このようなサービスのプロバイダーに高い成長機会を提供すると期待されています。世界中の製薬会社がワクチン治療やCOVID-19治療の開発のための臨床検査を開始したため、分析検査の需要が増加しています。また、コロナウイルスに対抗するため、顧客に配布する前に厳格な検査を受けなければならないヘルスケア機器や医薬品の世界の要件を満たす必要性が高まっていることも、産業の生産を後押ししています。このことは、このようなサービスの需要を増大させると予想されます。

ヘルスケア分析検査サービス市場レポートハイライト

  • ヘルスケア機器と医薬品市場には厳しい規制があるため、分析検査サービスが採用され、市場成長を牽引しています。
  • 医薬品分析検査サービス市場は、2024年に58.3%の最大市場シェアを占めました。
  • 北米は、米国に最大の臨床検査市場が存在するため、2024年には38.49%の収益シェアで世界市場を独占しました。
  • アジア太平洋は、予測期間中に8.92％のCAGRで最速の成長を遂げると予測されています。
  • この成長は、この地域に存在する様々な国々における新しい施設の開発と拡大によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヘルスケア分析検査サービス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 技術の情勢
  • 価格モデル分析
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • SWOT分析によるPESTEL
    • COVID-19の影響分析

第4章 ヘルスケア分析検査サービス市場：タイプ別、推定・動向分析

  • ヘルスケア分析検査サービス市場、タイプ別：セグメントダッシュボード
  • ヘルスケア分析検査サービス市場、タイプ別：変動分析
  • タイプ別、2018～2030年
  • ヘルスケア機器分析検査サービス
    • ヘルスケア機器分析検査サービス市場、2018～2030年
    • 抽出可能と浸出可能
    • 材料特性評価
    • 物理検査
    • バイオバーデン検査
    • 無菌検査
    • その他
  • 医薬品分析検査サービス
    • 医薬品分析検査サービス市場、2018～2030年
    • 生体分析検査
    • 方法の開発と検証
    • 安定性検査
    • その他の検査サービス

第5章 ヘルスケア分析検査サービス市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • タイ
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 市場参入企業の分類
    • マーケットリーダー
    • 新興参入企業
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • ICON plc
    • LabCorp
    • Charles River Laboratories International, Inc.
    • Syneos Health
    • SGS SA
    • Eurofins Scientific
    • Pace Analytical Services, LLC
    • Toxikon, Inc.
    • Intertek Group
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Healthcare Analytical Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Healthcare Analytical Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 UK Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 France Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Italy Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Spain Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Sweden Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Denmark Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Healthcare Analytical Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Japan Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 China Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 India Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Thailand Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 South Korea Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Australia Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Latin America Healthcare Analytical Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 29 Latin America Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Brazil Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Argentina Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Healthcare Analytical Testing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 UAE Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Healthcare Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Healthcare Analytical Testing Services Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Healthcare Analytical Testing Services Market snapshot
  • Fig. 11 Healthcare Analytical Testing Services Market driver impact
  • Fig. 12 Healthcare Analytical Testing Services Market restraint impact
  • Fig. 13 Healthcare Analytical Testing Services sector key takeaways (USD Million)
  • Fig. 14 Healthcare Analytical Testing Services Market: Type movement analysis
  • Fig. 15 Medical device analytical testing services market, 2018 - 2030 (USD Million)
  • Fig. 16 Extractable and leachable market, 2018 - 2030 (USD Million)
  • Fig. 17 Material characterization market, 2018 - 2030 (USD Million)
  • Fig. 18 Physical testing market, 2018 - 2030 (USD Million)
  • Fig. 19 Bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 20 Sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 21 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 22 Pharmaceutical analytical testing services market, 2018 - 2030 (USD Million)
  • Fig. 23 Bioanalytical testing market, 2018 - 2030 (USD Million)
  • Fig. 24 Method development and validation market, 2018 - 2030 (USD Million)
  • Fig. 25 Stability testing market, 2018 - 2030 (USD Million)
  • Fig. 26 Other testing services market, 2018 - 2030 (USD Million)
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Regional outlook, 2024 & 2030
  • Fig. 29 North America Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 34 UK Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 36 France Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Norway Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 China Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 45 India Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East & Africa Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 UAE Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Market participant categorization
目次
Product Code: GVR-4-68039-297-3

Healthcare Analytical Testing Services Market Growth & Trends:

The global healthcare analytical testing services market size is anticipated to reach USD 25.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.41% from 2025 to 2030. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines' approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services. As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights:

  • The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth.
  • The Pharmaceutical Analytical Testing Services market held the largest market share of 58.3% in 2024.
  • North America dominated the global market with the largest revenue share of 38.49% in 2024 owing to the presence of the largest clinical trials market in the U.S.
  • The Asia Pacific region is anticipated to grow at the fastest CAGR of 8.92% during the forecast period.
  • This growth can be credited to the development and expansion of new facilities in different countries present in this region.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis

  • 4.1. Healthcare Analytical Testing Services Market, By Type: Segment Dashboard
  • 4.2. Healthcare Analytical Testing Services Market, By Type: Movement Analysis
  • 4.3. Healthcare Analytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030
  • 4.4. Medical Device Analytical Testing Services
    • 4.4.1. Medical Device Analytical Testing Services Market, 2018 to 2030 (USD Million)
    • 4.4.2. Extractable and Leachable
      • 4.4.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
    • 4.4.3. Material Characterization
      • 4.4.3.1. Material Characterization Market, 2018 to 2030 (USD Million)
    • 4.4.4. Physical Testing
      • 4.4.4.1. Physical Testing Market, 2018 to 2030 (USD Million)
    • 4.4.5. Bioburden Testing
      • 4.4.5.1. Bioburden Testing Market, 2018 to 2030 (USD Million)
    • 4.4.6. Sterility Testing
      • 4.4.6.1. Sterility Testing Market, 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others Market, 2018 to 2030 (USD Million)
  • 4.5. Pharmaceutical Analytical Testing Services
    • 4.5.1. Pharmaceutical Analytical Testing Services Market, 2018 to 2030 (USD Million)
    • 4.5.2. Bioanalytical Testing
      • 4.5.2.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
    • 4.5.3. Method Development and Validation
      • 4.5.3.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
    • 4.5.4. Stability Testing
      • 4.5.4.1. Stability Testing Market, 2018 to 2030 (USD Million)
    • 4.5.5. Other Testing Services
      • 4.5.5.1. Other Testing Services Market, 2018 to 2030 (USD Million)

Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. North America
    • 5.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Competitive Scenario
      • 5.5.8.3. Regulatory Framework
      • 5.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Norway
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Competitive Scenario
      • 5.5.9.3. Regulatory Framework
      • 5.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Thailand
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. South Korea
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Australia
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Competitive Scenario
      • 5.8.4.3. Regulatory Framework
      • 5.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Competitive Scenario
      • 5.8.5.3. Regulatory Framework
      • 5.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
    • 6.1.1. Market Leaders
    • 6.1.2. Emerging Players
  • 6.2. Company Market Share/Assessment Analysis, 2024
  • 6.3. Company Profiles
    • 6.3.1. Thermo Fisher Scientific, Inc.
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Service Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. ICON plc
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Service Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. LabCorp
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Service Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Charles River Laboratories International, Inc.
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Service Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Syneos Health
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Service Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. SGS SA
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Service Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Eurofins Scientific
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Service Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Pace Analytical Services, LLC
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Service Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Toxikon, Inc.
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Service Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Intertek Group
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Service Benchmarking
      • 6.3.10.4. Strategic Initiatives